|
|
Volumn 10, Issue 9, 2014, Pages 513-
|
|
MTORC is a potential therapeutic target in APS
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AUTOANTIBODY;
IMMUNOGLOBULIN G;
MAMMALIAN TARGET OF RAPAMYCIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
RAPAMYCIN;
IMMUNOSUPPRESSIVE AGENT;
PHOSPHOLIPID ANTIBODY;
TARGET OF RAPAMYCIN KINASE;
ANTIPHOSPHOLIPID SYNDROME;
CAPILLARY ENDOTHELIAL CELL;
COHORT ANALYSIS;
DISEASE SEVERITY;
FIBROSIS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DISEASE;
KIDNEY FUNCTION;
KIDNEY GRAFT;
MEDICAL LITERATURE;
NOTE;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
THROMBOSIS;
DRUG ANTAGONISM;
FEMALE;
MALE;
METABOLISM;
VASCULAR ENDOTHELIUM;
ANTIBODIES, ANTIPHOSPHOLIPID;
ANTIPHOSPHOLIPID SYNDROME;
ENDOTHELIUM, VASCULAR;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
SIROLIMUS;
TOR SERINE-THREONINE KINASES;
|
|
EID: 84908093058
PISSN: 17594790
EISSN: 17594804
Source Type: Journal
DOI: 10.1038/nrrheum.2014.134 Document Type: Note |
|
Times cited : (2)
|
|
References (1)
|
